Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders

Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders

US Patent 9085584 · Granted Jul 21, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyridazinyl amino derivatives as ALK5 inhibitors2025
Imidazopyrazine derivatives and the use thereof as medicament2025
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide2025
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide2025
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide2025
CCR2 receptor antagonists and uses thereof2025
CCR2 receptor antagonists and uses thereof2025
Lubricating compositions with decarboxylated rosin acid2024
Substituted 3-phenoxyazetidin-1-yl-pyrazines2023
CCR2 receptor antagonists and uses thereof2023
CCR2 receptor antagonists and uses thereof2023
Cyclic ether derivatives of pyrazolo[1,5-A]pyrimidine-3-carboxyamide2023